Childhood Lensectomy Is Associated with Static and Dynamic Reduction in Schlemm Canal Size: A Biomechanical Hypothesis of Glaucoma after Lensectomy.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
02 2019
Historique:
received: 19 04 2018
revised: 13 08 2018
accepted: 24 08 2018
pubmed: 3 9 2018
medline: 18 12 2019
entrez: 3 9 2018
Statut: ppublish

Résumé

To compare Schlemm canal (SC) and trabecular meshwork (TM) in children with healthy eyes and those with and without glaucoma after lensectomy. Cross-sectional observational study. Fifty children 4 to 16 years of age with healthy eyes and 48 children who underwent lensectomy (124 healthy and 72 postlensectomy eyes). Anterior segment (AS) OCT (Tomey SS-1000 CASIA; Tomey, Nagoya, Japan) of the nasal iridocorneal angle at 2 levels of accommodative effort (2.5 diopters [D] and 15 D). For each parameter and state of accommodation, a random effects model was fitted to estimate differences between healthy eyes and eyes with history of lensectomy. Dimensions of SC and TM and conventional AS OCT iridocorneal angle measurements. The horizontal diameter of SC and its cross-sectional area (CSA) are significantly smaller in eyes that have undergone lensectomy versus healthy eyes. Accommodative effort increases SC size in healthy eyes, but not in eyes that have undergone lensectomy. Lensectomy is associated with a reduction in SC size and a loss of physiologic SC dilatation during accommodative effort, which may reflect a reduction in outflow facility and may contribute to the development of glaucoma after lensectomy.

Identifiants

pubmed: 30172708
pii: S0161-6420(18)30256-2
doi: 10.1016/j.ophtha.2018.08.031
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-241

Informations de copyright

Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Moritz C Daniel (MC)

National Institute of Health Research Biomedical Research Centre for Ophthalmology, University College London Institute of Ophthalmology, and Moorfields Eye Hospital, London, United Kingdom; Eye Center, Medical Center, University of Freiburg, Freiburg, Germany.

Adam M Dubis (AM)

National Institute of Health Research Biomedical Research Centre for Ophthalmology, University College London Institute of Ophthalmology, and Moorfields Eye Hospital, London, United Kingdom.

Maria Theodorou (M)

National Institute of Health Research Biomedical Research Centre for Ophthalmology, University College London Institute of Ophthalmology, and Moorfields Eye Hospital, London, United Kingdom; Pediatric Service, Moorfields Eye Hospital, London, United Kingdom.

Ana Quartilho (A)

National Institute of Health Research Biomedical Research Centre for Ophthalmology, University College London Institute of Ophthalmology, and Moorfields Eye Hospital, London, United Kingdom; Comprehensive Clinical Trials Unit, University College London, London, United Kingdom.

Gillian Adams (G)

Pediatric Service, Moorfields Eye Hospital, London, United Kingdom.

John Brookes (J)

Glaucoma Service, Moorfields Eye Hospital, London, United Kingdom.

Maria Papadopoulos (M)

Glaucoma Service, Moorfields Eye Hospital, London, United Kingdom.

Peng T Khaw (PT)

National Institute of Health Research Biomedical Research Centre for Ophthalmology, University College London Institute of Ophthalmology, and Moorfields Eye Hospital, London, United Kingdom; Glaucoma Service, Moorfields Eye Hospital, London, United Kingdom.

Annegret H Dahlmann-Noor (AH)

National Institute of Health Research Biomedical Research Centre for Ophthalmology, University College London Institute of Ophthalmology, and Moorfields Eye Hospital, London, United Kingdom; Pediatric Service, Moorfields Eye Hospital, London, United Kingdom. Electronic address: annegret.dahlmann-noor@moorfields.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH